Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RENOLD PLC Director's Dealing 2018

May 30, 2018

7879_dirs_2018-05-30_49b7cd7b-472b-40b0-8960-1688ed8f7956.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6547P

Renold PLC

30 May 2018

Renold plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Ian Scapens
2 Reason for the notification
a) Position/status Finance Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Renold plc
b) LEI 213800LNDGJY65SP6P54
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 5 pence each
Identification code GB0007325078
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
26.374p 189,580
d) Aggregated information
- Aggregated volume 189,580
- Price 26.374p
e) Date of the transaction 20 May 2018
f) Place of the transaction London Stock Exchange

Following this transaction the total beneficial Interest for Mr Ian Scapens is 189,580 Ordinary 5p Shares

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHGRGDULXXBGIG